The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma

The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma

Abstract To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. This study analyzed data from 70 N...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ruiqi Wang, Hao Tian, Zhenxing Zhu, Dan Cong, Yuansong Bai, Wenlong Zhang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-08-01
Series:	Scientific Reports
Subjects:	Recombinant human granulocyte stimulating factor Newly diagnosed multiple myeloma Autologous stem cell transplantation Hematopoietic reconstitution
Online Access:	https://doi.org/10.1038/s41598-025-15360-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Shirkhan Amikishiyev, et al.
Published: (2024-07-01)

Newly diagnosed atrial fibrillation detected by noninvasive screening methods in clinical practice
by: Luis Aguinaga, MD, MBA, PhD, RMFAC, FACC, FESC, et al.
Published: (2025-08-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2023-05-01)

Interventions for promoting physical activity in people with newly diagnosed Parkinson’s disease: scoping review
by: Jonathan Gilby, et al.
Published: (2025-08-01)

Mindfulness vs. sleep education during autologous hematopoietic cell transplantation for multiple myeloma: Feasibility of a randomized controlled pilot study
by: Elisabeth C. Henley, et al.
Published: (2025-10-01)

Application of autologous hemopoietic stem cells in inoperable patients with chronic critical lower limb ischemia
by: I. P. Mikhaylov, et al.
Published: (2022-04-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data
by: A. V. Popova, et al.
Published: (2025-03-01)

Myeloid-derived suppressor cells in multiple myeloma patients at the immune recovery and after high-dose chemotherapy and hematopoietic stem cell transplantation
by: T. V. Tyrinova, et al.
Published: (2023-01-01)

Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas
by: Yu. L. Shevchenko, et al.
Published: (2014-07-01)

A Comparative Study Between the Frequency of New Cases of Type 1 Diabetes Two Years Before and Two Years During COVID-19 Pandemic in Be’sat Hospital, Hamadan City, Iran
by: Mina Sadeghi, et al.
Published: (2025-01-01)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation
by: FU Xiaoyan, et al.
Published: (2025-07-01)

Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
by: Ida Erngren, et al.
Published: (2025-07-01)

Lost in translation: pluripotent stem cell‐derived hematopoiesis
by: Mania Ackermann, et al.
Published: (2015-07-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013-02-01)

Prevalence of newly diagnosed high blood pressure among female adults aged 18 to 50 years in south western Nigeria
by: Ngozi A. Ukangwa, et al.
Published: (2025-01-01)

Advances in the Treatment of Acute Myeloid Leukemia: Implications for Low- and Middle-Income Countries
by: Michelle Morcos-Sandino, et al.
Published: (2025-05-01)

Cyclosporine combined with eltrombopag for treatment of secondary graft failure after autologous hematopoietic stem cell transplantation
by: S. V. Semochkin, et al.
Published: (2024-09-01)

Autoimmune neutropenia: a rare complication of allogeneic hematopoietic stem cell transplantation?
by: María Isabel Benítez Carabante, et al.
Published: (2025-07-01)

Current status of hematopoietic stem cell transplantation in Russia
by: L. P. Mendeleeva, et al.
Published: (2022-11-01)

Pitfalls in the pathological diagnosis of multiple myeloma
by: V. V. Baykov
Published: (2022-11-01)

Cavenous Involvement in a Paint with Multiple Myeloma
by: Buket Tuğan Yıldız, et al.
Published: (2018-12-01)

Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup
by: Chandramouli Nagarajan, et al.
Published: (2025-06-01)

Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01)

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects
by: O. B. Ovsyannikova, et al.
Published: (2020-11-01)

A study to identify novel biomarkers associated with multiple myeloma
by: Bhaskar Kalarani Iyshwarya, et al.
Published: (2023-11-01)

Analysis of the short-to-intermediate-term efficacy of autologous costochondral transplantation in treatment for Hepple V osteochondral lesion of talus
by: Jiazheng Wang, et al.
Published: (2025-08-01)

Autologous serum supplementation promotes the phenotype maintenance of human chondrocytes with increased cellular autophagy
by: Wei Yin, et al.
Published: (2025-03-01)

Variants of storage and perioperative use of autologous blood components
by: Yu. S. Bocharova, et al.
Published: (2013-02-01)

The clinical case of cardiac amyloidosis associated with multiple myeloma
by: E. I. Tsoi, et al.
Published: (2020-07-01)

Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01)

Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
by: Twyla Bartel, et al.
Published: (2016-07-01)

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
by: Antoine Domenger, et al.
Published: (2022-01-01)

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

Multiple Myeloma with Intracranial Distribution
by: A. Yu. Rynda, et al.
Published: (2023-06-01)

In Vitro Evaluation of the PMN Reaction on a Collagen-Based Purified Reconstituted Bilayer Matrix (PRBM) Using the Autologous Blood Concentrate PRF
by: Eva Dohle, et al.
Published: (2025-05-01)

Predicting survival of persons with newly-diagnosed multiple myeloma
by: Limei Zhang, et al.
Published: (2025-08-01)

Clinical application of preoperative autologous blood donation under anesthesia monitoring
by: DU Chunhong, et al.
Published: (2025-05-01)